October 8, 2016
A German Court convicted two former employees of a pharmaceutical company with suspended sentences and a US$39 million fine was given to the company on bribery charges.
From 2007 to 2010 the two individuals from the company’s sales division were said to have made illicit payments to a consultancy advising one of the company’s clients in order to win more contracts. Details were not given on the client or market in which it operated. Further investigations were ongoing at the time of publication.